Board of Directors

The Foundation’s Board of Directors includes prominent gynecologic cancer experts from leading cancer centers and hospitals across the country.

Click on the names below for more information.

Executive Committee

David M. Gershenson, MD Chairman
Carol L. Brown, MD
Linda R. Duska, MD
Jeffrey M. Fowler, MD
William J. Hoskins, MD
David H. Moore, MD
Anil Sood, MD

Board of Directors
Michael J. Birrer, MD, PhD
Ilana Cass, MD
Charles N. Landen Jr., MD
George Larry Maxwell, MD
Karl C. Podratz, MD, PhD
Matthew A. Powell, MD
Laurel Rice, MD
Fidel Valea, MD
Richard R. Barakat, MD, Ex-Officio
Karen Carlson, Ex-Officio
Robert L. Coleman, MD, Ex-Officio

Spotlight

Visit the Sisterhood of Survivorship page to read “Dena’s Story” — by a vulvar cancer survivor who has shared her story and wise words, and channeled her energy into her National Race to End Women’s Cancer team.

Awareness

Vaccine efficacy against vulvar infection with HPV 16/18 was comparable to the efficacy found against cervical infection 4 years after vaccination, according to researchers with the National Cancer Institute.

Research

The Foundation has published its 2014-2015 Research Grants and Awards Booklet with Applications. Please consider applying to become part of an elite group of physician-scientists committed to the well-being of women at risk for/affected by gyn malignancies.

Education

The next Ovarian Cancer Survivors Course will be Saturday, July 26, 2014 in Boston. For more information on courses, click here.